Lucid Scientific Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Series A2
- Latest Deal Amount
-
$6.9M
- Investors
-
4
Lucid Scientific General Information
Description
Developer of metabolic cell analysis instruments designed for continuous bioenergetic monitoring. The company's platform measures real-time oxygen consumption and mitochondrial function across diverse plate formats and culture types inside standard incubators, enabling life science researchers to assess cell metabolism over extended experiments.
Contact Information
Website
www.lucidsci.comCorporate Office
- 1708 Peachtree Street NorthWest
- Suite 415
- Atlanta, GA 30309-7022
- United States
Corporate Office
- 1708 Peachtree Street NorthWest
- Suite 415
- Atlanta, GA 30309-7022
- United States
Lucid Scientific Timeline
Lucid Scientific Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A2) | 16-Jan-2025 | $6.9M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series A) | 05-Sep-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | $3M | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Oct-2020 | $3M | $3M | Completed | Generating Revenue |
Lucid Scientific Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed | 7,426,541 | $0.001000 | $0.05 | $0.62 | $0.62 | 1x | $0.62 | 23.26% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Lucid Scientific Patents
Lucid Scientific Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026019867-A1 | Multimodal sensing of biological samples | Pending | 16-Jul-2024 | ||
| CA-3222709-A1 | Lid with variable interlayer gap | Pending | 15-Jun-2021 | ||
| EP-4341376-A1 | Lid with variable interlayer gap | Pending | 15-Jun-2021 | ||
| JP-2024523312-A | Lid with variable interlayer gap | Pending | 15-Jun-2021 | ||
| US-20240279582-A1 | Lid with variable interlayer gap | Pending | 15-Jun-2021 | C12M23/38 |
Lucid Scientific Signals
Lucid Scientific Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| IAG Capital Partners | Venture Capital | Minority | ||
| Dynamk Capital | Venture Capital | Minority | ||
| GRA Venture Fund | Venture Capital | Minority | ||
| Advanced Technology Development Center | Accelerator/Incubator |
Lucid Scientific FAQs
-
When was Lucid Scientific founded?
Lucid Scientific was founded in 2012.
-
Where is Lucid Scientific headquartered?
Lucid Scientific is headquartered in Atlanta, GA.
-
What is the size of Lucid Scientific?
Lucid Scientific has 17 total employees.
-
What industry is Lucid Scientific in?
Lucid Scientific’s primary industry is Biotechnology.
-
Is Lucid Scientific a private or public company?
Lucid Scientific is a Private company.
-
What is Lucid Scientific’s current revenue?
The current revenue for Lucid Scientific is .
-
How much funding has Lucid Scientific raised over time?
Lucid Scientific has raised $19.9M.
-
Who are Lucid Scientific’s investors?
IAG Capital Partners, Dynamk Capital, GRA Venture Fund, and Advanced Technology Development Center have invested in Lucid Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process